Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways
Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important roles in tumorigenesis. However, the expression status and functional significance of Trop2 in thyroid cancer are largely unknown. We first dete...
Saved in:
| Published in | BMC cancer Vol. 17; no. 1; pp. 486 - 10 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
14.07.2017
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important roles in tumorigenesis. However, the expression status and functional significance of Trop2 in thyroid cancer are largely unknown.
We first determined the expression of Trop2 by using RNAseqV2 data sets for thyroid cancer deposited on The Cancer Genome Atlas (TCGA) website. The expression of Trop2 was then confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays. Cell invasion and migration were assessed by conducting Transwell and wound healing assays. Furthermore, we explored the underlying mechanisms by using real-time RT-PCR, Western blot, zymography, and luciferase reporter assays.
In this study, we demonstrated that the expression of Trop2 was significantly elevated in thyroid cancer and that its expression level was correlated with the tumor-node-metastasis (TNM) staging and N classification. Dysregulation of Trop2 altered the invasive capability of thyroid cancer cells. Further mechanistic study revealed that MMP2 expression was upregulated by Trop2. Moreover, we found that the effects of Trop2 were dependent on ERK and JNK pathways. The results from clinical specimens showed that Trop2 expression correlated with MMP2 expression in primary thyroid cancer.
The current study suggests that elevated expression of Trop2 may represent an important molecular hallmark that is biologically and clinically relevant to the progression of thyroid cancer. |
|---|---|
| AbstractList | Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important roles in tumorigenesis. However, the expression status and functional significance of Trop2 in thyroid cancer are largely unknown.
We first determined the expression of Trop2 by using RNAseqV2 data sets for thyroid cancer deposited on The Cancer Genome Atlas (TCGA) website. The expression of Trop2 was then confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays. Cell invasion and migration were assessed by conducting Transwell and wound healing assays. Furthermore, we explored the underlying mechanisms by using real-time RT-PCR, Western blot, zymography, and luciferase reporter assays.
In this study, we demonstrated that the expression of Trop2 was significantly elevated in thyroid cancer and that its expression level was correlated with the tumor-node-metastasis (TNM) staging and N classification. Dysregulation of Trop2 altered the invasive capability of thyroid cancer cells. Further mechanistic study revealed that MMP2 expression was upregulated by Trop2. Moreover, we found that the effects of Trop2 were dependent on ERK and JNK pathways. The results from clinical specimens showed that Trop2 expression correlated with MMP2 expression in primary thyroid cancer.
The current study suggests that elevated expression of Trop2 may represent an important molecular hallmark that is biologically and clinically relevant to the progression of thyroid cancer. Background Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important roles in tumorigenesis. However, the expression status and functional significance of Trop2 in thyroid cancer are largely unknown. Methods We first determined the expression of Trop2 by using RNAseqV2 data sets for thyroid cancer deposited on The Cancer Genome Atlas (TCGA) website. The expression of Trop2 was then confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays. Cell invasion and migration were assessed by conducting Transwell and wound healing assays. Furthermore, we explored the underlying mechanisms by using real-time RT-PCR, Western blot, zymography, and luciferase reporter assays. Results In this study, we demonstrated that the expression of Trop2 was significantly elevated in thyroid cancer and that its expression level was correlated with the tumor-node-metastasis (TNM) staging and N classification. Dysregulation of Trop2 altered the invasive capability of thyroid cancer cells. Further mechanistic study revealed that MMP2 expression was upregulated by Trop2. Moreover, we found that the effects of Trop2 were dependent on ERK and JNK pathways. The results from clinical specimens showed that Trop2 expression correlated with MMP2 expression in primary thyroid cancer. Conclusion The current study suggests that elevated expression of Trop2 may represent an important molecular hallmark that is biologically and clinically relevant to the progression of thyroid cancer. Keywords: Trop2, Thyroid cancer, Invasion, MMP2, MAPK Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important roles in tumorigenesis. However, the expression status and functional significance of Trop2 in thyroid cancer are largely unknown.BACKGROUNDMounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important roles in tumorigenesis. However, the expression status and functional significance of Trop2 in thyroid cancer are largely unknown.We first determined the expression of Trop2 by using RNAseqV2 data sets for thyroid cancer deposited on The Cancer Genome Atlas (TCGA) website. The expression of Trop2 was then confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays. Cell invasion and migration were assessed by conducting Transwell and wound healing assays. Furthermore, we explored the underlying mechanisms by using real-time RT-PCR, Western blot, zymography, and luciferase reporter assays.METHODSWe first determined the expression of Trop2 by using RNAseqV2 data sets for thyroid cancer deposited on The Cancer Genome Atlas (TCGA) website. The expression of Trop2 was then confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays. Cell invasion and migration were assessed by conducting Transwell and wound healing assays. Furthermore, we explored the underlying mechanisms by using real-time RT-PCR, Western blot, zymography, and luciferase reporter assays.In this study, we demonstrated that the expression of Trop2 was significantly elevated in thyroid cancer and that its expression level was correlated with the tumor-node-metastasis (TNM) staging and N classification. Dysregulation of Trop2 altered the invasive capability of thyroid cancer cells. Further mechanistic study revealed that MMP2 expression was upregulated by Trop2. Moreover, we found that the effects of Trop2 were dependent on ERK and JNK pathways. The results from clinical specimens showed that Trop2 expression correlated with MMP2 expression in primary thyroid cancer.RESULTSIn this study, we demonstrated that the expression of Trop2 was significantly elevated in thyroid cancer and that its expression level was correlated with the tumor-node-metastasis (TNM) staging and N classification. Dysregulation of Trop2 altered the invasive capability of thyroid cancer cells. Further mechanistic study revealed that MMP2 expression was upregulated by Trop2. Moreover, we found that the effects of Trop2 were dependent on ERK and JNK pathways. The results from clinical specimens showed that Trop2 expression correlated with MMP2 expression in primary thyroid cancer.The current study suggests that elevated expression of Trop2 may represent an important molecular hallmark that is biologically and clinically relevant to the progression of thyroid cancer.CONCLUSIONThe current study suggests that elevated expression of Trop2 may represent an important molecular hallmark that is biologically and clinically relevant to the progression of thyroid cancer. Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important roles in tumorigenesis. However, the expression status and functional significance of Trop2 in thyroid cancer are largely unknown. We first determined the expression of Trop2 by using RNAseqV2 data sets for thyroid cancer deposited on The Cancer Genome Atlas (TCGA) website. The expression of Trop2 was then confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays. Cell invasion and migration were assessed by conducting Transwell and wound healing assays. Furthermore, we explored the underlying mechanisms by using real-time RT-PCR, Western blot, zymography, and luciferase reporter assays. In this study, we demonstrated that the expression of Trop2 was significantly elevated in thyroid cancer and that its expression level was correlated with the tumor-node-metastasis (TNM) staging and N classification. Dysregulation of Trop2 altered the invasive capability of thyroid cancer cells. Further mechanistic study revealed that MMP2 expression was upregulated by Trop2. Moreover, we found that the effects of Trop2 were dependent on ERK and JNK pathways. The results from clinical specimens showed that Trop2 expression correlated with MMP2 expression in primary thyroid cancer. The current study suggests that elevated expression of Trop2 may represent an important molecular hallmark that is biologically and clinically relevant to the progression of thyroid cancer. Background Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important roles in tumorigenesis. However, the expression status and functional significance of Trop2 in thyroid cancer are largely unknown. Methods We first determined the expression of Trop2 by using RNAseqV2 data sets for thyroid cancer deposited on The Cancer Genome Atlas (TCGA) website. The expression of Trop2 was then confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays. Cell invasion and migration were assessed by conducting Transwell and wound healing assays. Furthermore, we explored the underlying mechanisms by using real-time RT-PCR, Western blot, zymography, and luciferase reporter assays. Results In this study, we demonstrated that the expression of Trop2 was significantly elevated in thyroid cancer and that its expression level was correlated with the tumor-node-metastasis (TNM) staging and N classification. Dysregulation of Trop2 altered the invasive capability of thyroid cancer cells. Further mechanistic study revealed that MMP2 expression was upregulated by Trop2. Moreover, we found that the effects of Trop2 were dependent on ERK and JNK pathways. The results from clinical specimens showed that Trop2 expression correlated with MMP2 expression in primary thyroid cancer. Conclusion The current study suggests that elevated expression of Trop2 may represent an important molecular hallmark that is biologically and clinically relevant to the progression of thyroid cancer. Abstract Background Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important roles in tumorigenesis. However, the expression status and functional significance of Trop2 in thyroid cancer are largely unknown. Methods We first determined the expression of Trop2 by using RNAseqV2 data sets for thyroid cancer deposited on The Cancer Genome Atlas (TCGA) website. The expression of Trop2 was then confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays. Cell invasion and migration were assessed by conducting Transwell and wound healing assays. Furthermore, we explored the underlying mechanisms by using real-time RT-PCR, Western blot, zymography, and luciferase reporter assays. Results In this study, we demonstrated that the expression of Trop2 was significantly elevated in thyroid cancer and that its expression level was correlated with the tumor-node-metastasis (TNM) staging and N classification. Dysregulation of Trop2 altered the invasive capability of thyroid cancer cells. Further mechanistic study revealed that MMP2 expression was upregulated by Trop2. Moreover, we found that the effects of Trop2 were dependent on ERK and JNK pathways. The results from clinical specimens showed that Trop2 expression correlated with MMP2 expression in primary thyroid cancer. Conclusion The current study suggests that elevated expression of Trop2 may represent an important molecular hallmark that is biologically and clinically relevant to the progression of thyroid cancer. |
| ArticleNumber | 486 |
| Audience | Academic |
| Author | Liang, Weiwei Wei, Guohong Guan, Hongyu Xiao, Haipeng Guo, Zejun Xu, Lijuan Li, Hai Li, Yanbing |
| Author_xml | – sequence: 1 givenname: Hongyu surname: Guan fullname: Guan, Hongyu – sequence: 2 givenname: Zejun surname: Guo fullname: Guo, Zejun – sequence: 3 givenname: Weiwei surname: Liang fullname: Liang, Weiwei – sequence: 4 givenname: Hai surname: Li fullname: Li, Hai – sequence: 5 givenname: Guohong surname: Wei fullname: Wei, Guohong – sequence: 6 givenname: Lijuan surname: Xu fullname: Xu, Lijuan – sequence: 7 givenname: Haipeng surname: Xiao fullname: Xiao, Haipeng – sequence: 8 givenname: Yanbing surname: Li fullname: Li, Yanbing |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28709407$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kktv1DAURiNURB_wA9igSEgIFim2E8fOBqmqCgxtAZUilpafiUcZe7CTwvx7HKaFSQXJItG9554kN99htue801n2FIJjCGn9OkJEKS4AJEVZEVygB9kBrAgsUAXI3s79fnYY4xIkkAL6KNtHlIAm1Q-yb9fBr1GuXced1DG37oZH613uTT50m-CtyuXUCrnYpK4apXVtfnn5GaV-8GPb5WdX5zl3Kv_w8Txf86H7wTfxcfbQ8D7qJ7fXo-zr27Pr0_fFxad3i9OTi0LWDRwKIWvEK15RYripGkJFY0opudFAN1IBIyusCRSoBNRghIXWpVINFggrjYAqj7LF1qs8X7J1sCseNsxzy34XfGgZD4OVvWZV4ik1lDaQVxpgQSoohFB1aQDRQibXm61rPYqVVlK7IfB-Jp13nO1Y628YxrAEiCbBy1tB8N9HHQe2slHqvudO-zEy2CAAG1wTkNDn99ClH4NLq5oojEg66F-q5ekDrDM-PVdOUnaCYfr7DSEoUcf_oNKp9MrKFBljU3028Go2kJhB_xxaPsbIFl-u5uyLHbbTvB-66PtxSCGJc_DZ7vb-rO0uawkgW0AGH2PQhkk78MmTXtf2DAI2pZptU81SWNmUajap4b3JO_n_Z34Bn4z2HA |
| CitedBy_id | crossref_primary_10_1016_j_pharmthera_2022_108296 crossref_primary_10_1158_1535_7163_MCT_21_0206 crossref_primary_10_2174_1381612826666200429092742 crossref_primary_10_1007_s00432_022_04017_x crossref_primary_10_1007_s00405_018_5045_x crossref_primary_10_1177_0300060518822913 crossref_primary_10_1097_MD_0000000000029760 crossref_primary_10_1155_2019_7043509 crossref_primary_10_1177_0963689718786882 crossref_primary_10_1007_s12070_020_02275_0 crossref_primary_10_1038_s44321_024_00059_5 crossref_primary_10_3390_pharmaceutics14102218 crossref_primary_10_1073_pnas_1905384117 crossref_primary_10_1177_2632010X19863047 crossref_primary_10_2174_1389203723666220530102720 crossref_primary_10_1016_j_jnutbio_2023_109417 crossref_primary_10_1007_s12079_023_00742_1 crossref_primary_10_1158_1078_0432_CCR_23_2566 crossref_primary_10_3892_etm_2019_7969 crossref_primary_10_1016_j_saa_2019_117693 crossref_primary_10_1186_s13578_018_0256_9 crossref_primary_10_1159_000494430 crossref_primary_10_3892_ol_2023_14114 crossref_primary_10_17650_2313_805X_2024_11_3_32_40 crossref_primary_10_3389_fonc_2020_605737 crossref_primary_10_1016_j_placenta_2024_07_055 crossref_primary_10_1186_s40364_024_00633_6 crossref_primary_10_3390_cancers12113328 crossref_primary_10_1021_acs_molpharmaceut_4c00848 crossref_primary_10_1002_cbf_3361 crossref_primary_10_3892_ijo_2018_4423 crossref_primary_10_1016_j_acthis_2020_151635 crossref_primary_10_1016_j_cyto_2024_156841 crossref_primary_10_3390_cancers15061744 crossref_primary_10_1016_j_bbcan_2023_188902 crossref_primary_10_1093_carcin_bgae082 crossref_primary_10_3389_fcell_2021_758339 crossref_primary_10_1007_s10142_022_00892_2 crossref_primary_10_1002_cbf_3450 crossref_primary_10_1016_j_bbcan_2020_188436 crossref_primary_10_3892_ijo_2020_5041 crossref_primary_10_1007_s11845_022_02976_1 crossref_primary_10_18632_aging_103570 crossref_primary_10_3892_mmr_2018_9083 crossref_primary_10_1080_15384101_2018_1558869 crossref_primary_10_3390_ijms25010087 crossref_primary_10_1016_j_abb_2021_109084 crossref_primary_10_1016_j_cellsig_2020_109745 crossref_primary_10_1016_j_bbrep_2020_100902 crossref_primary_10_3233_CBM_230230 |
| Cites_doi | 10.1038/nature00766 10.1038/onc.2012.151 10.1089/thy.2015.0116 10.1172/JCI23237 10.1016/j.ejca.2009.12.019 10.1007/s10555-014-9530-4 10.7150/jca.2.193 10.1158/0008-5472.CAN-12-3266 10.1007/s00384-009-0725-z 10.1369/0022155411410430 10.1073/pnas.78.8.5147 10.1016/j.ajog.2011.06.093 10.1038/nrendo.2014.100 10.1371/journal.pone.0075864 10.1002/(SICI)1097-0215(19980529)76:5<671::AID-IJC10>3.0.CO;2-7 10.1158/0008-5472.CAN-04-3785 10.1080/07853890600551037 10.1089/thy.2014.0155 10.1007/s10072-013-1326-8 10.1007/s00428-013-1475-4 10.1038/nrc3431 10.1038/nrc1836 10.3892/mmr.2015.3485 10.1385/CBB:43:3:451 10.1002/ijc.28451 10.1002/path.1400 10.1038/onc.2012.36 10.1210/jcem-73-4-832 10.1016/j.mce.2015.01.037 10.1002/emmm.201200222 10.18632/oncotarget.5566 10.1038/sj.bjc.6604677 10.1111/cyt.12196 10.1097/01.ASN.0000015609.31253.7F 10.1210/jc.2013-4140 10.1530/eje.1.02289 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2017 BioMed Central Ltd. Copyright BioMed Central 2017 The Author(s). 2017 |
| Copyright_xml | – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: Copyright BioMed Central 2017 – notice: The Author(s). 2017 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12885-017-3475-2 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2407 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_420d88f8891a4e05b741bbbd63f07ebc PMC5513028 A511289772 28709407 10_1186_s12885_017_3475_2 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: ; grantid: 81572623; 81572624; 81602347 – fundername: ; grantid: 81370076 – fundername: ; grantid: 2016A030310169 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW INH INR ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7TO 7XB 8FK AHSBF AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c691t-bc62a4a487faf4978b9f3ccafe0e9cd0fc45e71b2308f525bee3dd95b25de20d3 |
| IEDL.DBID | M48 |
| ISSN | 1471-2407 |
| IngestDate | Wed Aug 27 01:23:33 EDT 2025 Thu Aug 21 18:41:54 EDT 2025 Thu Jul 10 19:02:25 EDT 2025 Fri Jul 25 06:01:58 EDT 2025 Tue Jun 17 21:49:30 EDT 2025 Tue Jun 10 20:08:47 EDT 2025 Fri Jun 27 04:45:14 EDT 2025 Thu May 22 21:23:23 EDT 2025 Thu Jan 02 23:09:20 EST 2025 Tue Jul 01 03:06:00 EDT 2025 Thu Apr 24 22:54:08 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Thyroid cancer MAPK MMP2 Trop2 Invasion |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c691t-bc62a4a487faf4978b9f3ccafe0e9cd0fc45e71b2308f525bee3dd95b25de20d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12885-017-3475-2 |
| PMID | 28709407 |
| PQID | 1925277778 |
| PQPubID | 44074 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_420d88f8891a4e05b741bbbd63f07ebc pubmedcentral_primary_oai_pubmedcentral_nih_gov_5513028 proquest_miscellaneous_1920195670 proquest_journals_1925277778 gale_infotracmisc_A511289772 gale_infotracacademiconefile_A511289772 gale_incontextgauss_ISR_A511289772 gale_healthsolutions_A511289772 pubmed_primary_28709407 crossref_citationtrail_10_1186_s12885_017_3475_2 crossref_primary_10_1186_s12885_017_3475_2 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-07-14 |
| PublicationDateYYYYMMDD | 2017-07-14 |
| PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-14 day: 14 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC cancer |
| PublicationTitleAlternate | BMC Cancer |
| PublicationYear | 2017 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | J Varughese (3475_CR9) 2011; 205 R Ciampi (3475_CR18) 2005; 115 N Nilubol (3475_CR4) 2014; 99 D Fong (3475_CR12) 2008; 99 I Stamenkovic (3475_CR36) 2003; 200 E Bignotti (3475_CR10) 2010; 46 RA MacCorkle (3475_CR15) 2005; 43 JC Lin (3475_CR6) 2012; 4 YJ Fang (3475_CR28) 2009; 24 XD Wang (3475_CR34) 2015; 12 M Trerotola (3475_CR8) 2013; 32 S Ning (3475_CR32) 2013; 34 S Vaccarella (3475_CR1) 2015; 25 RL Brown (3475_CR3) 2011; 2 E Guerra (3475_CR31) 2013; 32 T Liu (3475_CR13) 2013; 8 M Xing (3475_CR19) 2013; 13 C Viedt (3475_CR26) 2002; 13 M Kohno (3475_CR16) 2006; 38 M Santoro (3475_CR21) 2006; 155 T Addati (3475_CR14) 2015; 26 LP Stepan (3475_CR30) 2011; 59 W Liang (3475_CR25) 2015; 6 E Ripani (3475_CR7) 1998; 76 H Lin (3475_CR33) 2014; 134 H Davies (3475_CR22) 2002; 417 WK Kwok (3475_CR24) 2005; 65 H Karga (3475_CR20) 1991; 73 T Kondo (3475_CR17) 2006; 6 M Tauro (3475_CR35) 2014; 33 M Luster (3475_CR2) 2014; 10 H Guan (3475_CR23) 2015; 25 M Lipinski (3475_CR5) 1981; 78 R Chen (3475_CR11) 2013; 463 M Trerotola (3475_CR27) 2013; 73 V Kalhori (3475_CR29) 2015; 404 25325988 - Cancer Metastasis Rev. 2014 Dec;33(4):1043-57 12039983 - J Am Soc Nephrol. 2002 Jun;13(6):1534-47 1890154 - J Clin Endocrinol Metab. 1991 Oct;73(4):832-6 9610724 - Int J Cancer. 1998 May 29;76(5):671-6 12068308 - Nature. 2002 Jun 27;417(6892):949-54 20060709 - Eur J Cancer. 2010 Mar;46(5):944-53 26133012 - Thyroid. 2015 Oct;25(10):1127-36 18813308 - Br J Cancer. 2008 Oct 21;99(8):1290-5 24086649 - PLoS One. 2013 Sep 27;8(9):e75864 21889762 - Am J Obstet Gynecol. 2011 Dec;205(6):567.e1-7 17062879 - Eur J Endocrinol. 2006 Nov;155(5):645-53 21509149 - J Cancer. 2011 Apr 04;2:193-9 16244369 - Cell Biochem Biophys. 2005;43(3):451-61 21551320 - J Histochem Cytochem. 2011 Jul;59(7):701-10 25244400 - Thyroid. 2015 Jan;25(1):85-94 22349828 - Oncogene. 2013 Jan 10;32(2):222-33 23979406 - Virchows Arch. 2013 Nov;463(5):713-9 12845612 - J Pathol. 2003 Jul;200(4):448-64 15958559 - Cancer Res. 2005 Jun 15;65(12 ):5153-62 25643979 - Mol Cell Endocrinol. 2015 Mar 15;404:113-22 7029529 - Proc Natl Acad Sci U S A. 1981 Aug;78(8):5147-50 25779928 - Mol Med Rep. 2015 Jul;12(1):865-70 15630448 - J Clin Invest. 2005 Jan;115(1):94-101 22419550 - EMBO Mol Med. 2012 Jun;4(6):472-85 19421758 - Int J Colorectal Dis. 2009 Aug;24(8):875-84 23982827 - Int J Cancer. 2014 Mar 1;134(5):1239-49 26378658 - Oncotarget. 2015 Oct 13;6(31):31780-91 16720434 - Ann Med. 2006;38(3):200-11 24981455 - Nat Rev Endocrinol. 2014 Sep;10(9):563-74 23429735 - Nat Rev Cancer. 2013 Mar;13(3):184-99 23397225 - Neurol Sci. 2013 Oct;34(10):1745-50 23536555 - Cancer Res. 2013 May 15;73(10):3155-67 24654752 - J Clin Endocrinol Metab. 2014 Jul;99(7):E1173-82 25164548 - Cytopathology. 2015 Oct;26(5):303-11 22562244 - Oncogene. 2013 Mar 21;32(12 ):1594-600 16557281 - Nat Rev Cancer. 2006 Apr;6(4):292-306 |
| References_xml | – volume: 417 start-page: 949 issue: 6892 year: 2002 ident: 3475_CR22 publication-title: Nature doi: 10.1038/nature00766 – volume: 32 start-page: 1594 issue: 12 year: 2013 ident: 3475_CR31 publication-title: Oncogene doi: 10.1038/onc.2012.151 – volume: 25 start-page: 1127 issue: 10 year: 2015 ident: 3475_CR1 publication-title: Thyroid doi: 10.1089/thy.2015.0116 – volume: 115 start-page: 94 issue: 1 year: 2005 ident: 3475_CR18 publication-title: J Clin Invest doi: 10.1172/JCI23237 – volume: 46 start-page: 944 issue: 5 year: 2010 ident: 3475_CR10 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2009.12.019 – volume: 33 start-page: 1043 issue: 4 year: 2014 ident: 3475_CR35 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-014-9530-4 – volume: 2 start-page: 193 year: 2011 ident: 3475_CR3 publication-title: J Cancer doi: 10.7150/jca.2.193 – volume: 73 start-page: 3155 issue: 10 year: 2013 ident: 3475_CR27 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-3266 – volume: 24 start-page: 875 issue: 8 year: 2009 ident: 3475_CR28 publication-title: Int J Color Dis doi: 10.1007/s00384-009-0725-z – volume: 59 start-page: 701 issue: 7 year: 2011 ident: 3475_CR30 publication-title: J Histochem Cytochem doi: 10.1369/0022155411410430 – volume: 78 start-page: 5147 issue: 8 year: 1981 ident: 3475_CR5 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.78.8.5147 – volume: 205 start-page: 567 e1 issue: o year: 2011 ident: 3475_CR9 publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2011.06.093 – volume: 10 start-page: 563 issue: 9 year: 2014 ident: 3475_CR2 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2014.100 – volume: 8 start-page: e75864 issue: 9 year: 2013 ident: 3475_CR13 publication-title: PLoS One doi: 10.1371/journal.pone.0075864 – volume: 76 start-page: 671 issue: 5 year: 1998 ident: 3475_CR7 publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(19980529)76:5<671::AID-IJC10>3.0.CO;2-7 – volume: 65 start-page: 5153 issue: 12 year: 2005 ident: 3475_CR24 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-3785 – volume: 38 start-page: 200 issue: 3 year: 2006 ident: 3475_CR16 publication-title: Ann Med doi: 10.1080/07853890600551037 – volume: 25 start-page: 85 issue: 1 year: 2015 ident: 3475_CR23 publication-title: Thyroid doi: 10.1089/thy.2014.0155 – volume: 34 start-page: 1745 issue: 10 year: 2013 ident: 3475_CR32 publication-title: Neurol Sci doi: 10.1007/s10072-013-1326-8 – volume: 463 start-page: 713 issue: 5 year: 2013 ident: 3475_CR11 publication-title: Virchows Arch doi: 10.1007/s00428-013-1475-4 – volume: 13 start-page: 184 issue: 3 year: 2013 ident: 3475_CR19 publication-title: Nat Rev Cancer doi: 10.1038/nrc3431 – volume: 6 start-page: 292 issue: 4 year: 2006 ident: 3475_CR17 publication-title: Nat Rev Cancer doi: 10.1038/nrc1836 – volume: 12 start-page: 865 issue: 1 year: 2015 ident: 3475_CR34 publication-title: Mol Med Rep doi: 10.3892/mmr.2015.3485 – volume: 43 start-page: 451 issue: 3 year: 2005 ident: 3475_CR15 publication-title: Cell Biochem Biophys doi: 10.1385/CBB:43:3:451 – volume: 134 start-page: 1239 issue: 5 year: 2014 ident: 3475_CR33 publication-title: Int J Cancer doi: 10.1002/ijc.28451 – volume: 200 start-page: 448 issue: 4 year: 2003 ident: 3475_CR36 publication-title: J Pathol doi: 10.1002/path.1400 – volume: 32 start-page: 222 issue: 2 year: 2013 ident: 3475_CR8 publication-title: Oncogene doi: 10.1038/onc.2012.36 – volume: 73 start-page: 832 issue: 4 year: 1991 ident: 3475_CR20 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-73-4-832 – volume: 404 start-page: 113 year: 2015 ident: 3475_CR29 publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2015.01.037 – volume: 4 start-page: 472 issue: 6 year: 2012 ident: 3475_CR6 publication-title: EMBO Mol Med doi: 10.1002/emmm.201200222 – volume: 6 start-page: 31780 issue: 31 year: 2015 ident: 3475_CR25 publication-title: Oncotarget doi: 10.18632/oncotarget.5566 – volume: 99 start-page: 1290 issue: 8 year: 2008 ident: 3475_CR12 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6604677 – volume: 26 start-page: 303 issue: 5 year: 2015 ident: 3475_CR14 publication-title: Cytopathology doi: 10.1111/cyt.12196 – volume: 13 start-page: 1534 issue: 6 year: 2002 ident: 3475_CR26 publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000015609.31253.7F – volume: 99 start-page: E1173 issue: 7 year: 2014 ident: 3475_CR4 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-4140 – volume: 155 start-page: 645 issue: 5 year: 2006 ident: 3475_CR21 publication-title: Eur J Endocrinol doi: 10.1530/eje.1.02289 – reference: 25164548 - Cytopathology. 2015 Oct;26(5):303-11 – reference: 25325988 - Cancer Metastasis Rev. 2014 Dec;33(4):1043-57 – reference: 23979406 - Virchows Arch. 2013 Nov;463(5):713-9 – reference: 12845612 - J Pathol. 2003 Jul;200(4):448-64 – reference: 25643979 - Mol Cell Endocrinol. 2015 Mar 15;404:113-22 – reference: 12068308 - Nature. 2002 Jun 27;417(6892):949-54 – reference: 18813308 - Br J Cancer. 2008 Oct 21;99(8):1290-5 – reference: 25779928 - Mol Med Rep. 2015 Jul;12(1):865-70 – reference: 20060709 - Eur J Cancer. 2010 Mar;46(5):944-53 – reference: 26378658 - Oncotarget. 2015 Oct 13;6(31):31780-91 – reference: 22562244 - Oncogene. 2013 Mar 21;32(12 ):1594-600 – reference: 15630448 - J Clin Invest. 2005 Jan;115(1):94-101 – reference: 16720434 - Ann Med. 2006;38(3):200-11 – reference: 23429735 - Nat Rev Cancer. 2013 Mar;13(3):184-99 – reference: 9610724 - Int J Cancer. 1998 May 29;76(5):671-6 – reference: 12039983 - J Am Soc Nephrol. 2002 Jun;13(6):1534-47 – reference: 21509149 - J Cancer. 2011 Apr 04;2:193-9 – reference: 24981455 - Nat Rev Endocrinol. 2014 Sep;10(9):563-74 – reference: 17062879 - Eur J Endocrinol. 2006 Nov;155(5):645-53 – reference: 21889762 - Am J Obstet Gynecol. 2011 Dec;205(6):567.e1-7 – reference: 22419550 - EMBO Mol Med. 2012 Jun;4(6):472-85 – reference: 26133012 - Thyroid. 2015 Oct;25(10):1127-36 – reference: 15958559 - Cancer Res. 2005 Jun 15;65(12 ):5153-62 – reference: 24086649 - PLoS One. 2013 Sep 27;8(9):e75864 – reference: 21551320 - J Histochem Cytochem. 2011 Jul;59(7):701-10 – reference: 19421758 - Int J Colorectal Dis. 2009 Aug;24(8):875-84 – reference: 23536555 - Cancer Res. 2013 May 15;73(10):3155-67 – reference: 22349828 - Oncogene. 2013 Jan 10;32(2):222-33 – reference: 23397225 - Neurol Sci. 2013 Oct;34(10):1745-50 – reference: 16244369 - Cell Biochem Biophys. 2005;43(3):451-61 – reference: 7029529 - Proc Natl Acad Sci U S A. 1981 Aug;78(8):5147-50 – reference: 23982827 - Int J Cancer. 2014 Mar 1;134(5):1239-49 – reference: 24654752 - J Clin Endocrinol Metab. 2014 Jul;99(7):E1173-82 – reference: 25244400 - Thyroid. 2015 Jan;25(1):85-94 – reference: 16557281 - Nat Rev Cancer. 2006 Apr;6(4):292-306 – reference: 1890154 - J Clin Endocrinol Metab. 1991 Oct;73(4):832-6 |
| SSID | ssj0017808 |
| Score | 2.4279451 |
| Snippet | Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important... Background Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays... Abstract Background Mounting evidence has showed that Tumor-associated calcium signal transducer 2 (Trop2) is upregulated in various kinds of human cancers and... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 486 |
| SubjectTerms | Aged Antigens, Neoplasm - genetics Calcium signalling Care and treatment Cell Adhesion Molecules - genetics Cell Line, Tumor Cell Movement - genetics Cell Proliferation - genetics Cellular signal transduction Development and progression Extracellular signal-regulated kinase Female Gelatinase A Gene Expression Regulation, Neoplastic - genetics Genetic aspects Genomes Health aspects Humans Immunohistochemistry Invasion Invasiveness JNK protein Kinases Male MAP Kinase Kinase 4 - genetics MAP Kinase Signaling System - genetics MAPK Matrix Metalloproteinase 2 - genetics Medical prognosis Metastases Metastasis Middle Aged MMP2 Mutation Neoplasm Invasiveness - genetics Neoplasm Staging Phosphotransferases Polymerase chain reaction Prostate cancer Proteins Reverse transcription Signal Transduction - genetics Thyroid cancer Thyroid Neoplasms - genetics Thyroid Neoplasms - pathology Trop2 Tumorigenesis Wound healing |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEF-kD-KL-G206iqCIITmNrvZzWOVltpyRWqLfVv2sz2QpFzulP73ziR74YKgL95jZpbczcfOzO3sbwh5b401EAnq3JbR59x4m0NU5Ln0gfnoq7rs4Rjmp9XRBT--FJdbo76wJ2yABx4Et8dZ4ZWKStUzw0MhLIRAa62vyljIYB3uvhDzNsVUOj-QqlDpDHOmqr0OdmGFTWrgUFyKnE2iUA_W_-eWvBWTpv2SWwHo8AG5nzJHuj9844fkTmgekbvzdDb-mHw_X7Y3jIbmGhXZ0UXz0-BfYbSNFLSxbBeeOiQtqb0Fql_Duis6n39lNE3roQdnJ9Q0nh6fnlCcVfzL3HZPyMXhwfnnozyNTchdVc9WuXUVM9xAJRJNxAFyto4lKCqGItTOF9FxEeTMQvGhomDChlB6XwvLBCio8OVTstO0TXhOqFXSxlgbJ4LhzjkbuXWBCROLGLiTGSk2YtQuYYrjaIsfuq8tVKUHyWuQvEbJa5aRj-OSmwFQ42_Mn1A3IyNiYfcPwEJ0shD9LwvJyBvUrB4ulo4erfcx11SQ_8Jr3vUciIfRYMPNlVl3nf7y7WzC9CExxRZ-ozPp_gJICiG0Jpy7E05wWDclb0xMpw2j05BoCybhozLydiTjSmyCa0K77nn6652yyMizwSJHyeB5dQ3FeUbkxFYnoptSmsV1DyeOI34gy3zxP2T9ktxj6GWIPMp3yc5quQ6vIGtb2de9g_4GQA8_1g priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1da9RAcNEK4ov4bbTqKoIghCabTXbzJFVaassVqS3e27Kf1wNJzsud0n_vTG4vNgjN480syc337M7OEPLeaKPBE9SpKYJLuXYmBa_IU-E8c8FVddG3Y5icVkcX_HhaTuOGWxfLKrc2sTfUrrW4R74HkUjJBDzy0-JXilOj8HQ1jtC4Te5g6zKUajEdEq5cyEzGk8xcVnsd2GKJpWqgVlyUKRv5or5l__-G-ZpnGldNXnNDhw_I_Rg_0v0Nwx-SW755RO5O4gn5Y_LjfNkuGPXNJbKzo_Pmt8YNMdoGCjxZtnNHLYKW1FwB1K1h3YxOJt8YjTN76MHZCdWNo8enJxQnFv_RV90TcnF4cP7lKI3DE1Jb1fkqNbZimmvIR4IOOEbO1KEAdgWf-dq6LFheepEbSEFkKFlpvC-cq0vDSmBT5oqnZKdpG_-cUCOFCaHWtvSaW2tN4MZ6VuqQBc-tSEi2JaOysbM4Drj4qfoMQ1ZqQ3kFlFdIecUS8nFYsti01bgJ-TPyZkDEjtj9D-1ypqKCKQ7fLGWQss4191lpIFQyxriqCJnwxibkDXJWba6XDnqt9jHilBAFw2ve9RjYFaPBspuZXned-vr9bIT0ISKFFv6j1fEWA1AKG2mNMHdHmKC2dgzeipiKZqNT_4Q8IW8HMK7EUrjGt-sep7_kKbKEPNtI5EAZPLWuIUVPiBjJ6oh0Y0gzv-ybiuOgH4g1X9z8WS_JPYb6g51F-S7ZWS3X_hVEZSvzule9v2GnNv4 priority: 102 providerName: ProQuest |
| Title | Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28709407 https://www.proquest.com/docview/1925277778 https://www.proquest.com/docview/1920195670 https://pubmed.ncbi.nlm.nih.gov/PMC5513028 https://doaj.org/article/420d88f8891a4e05b741bbbd63f07ebc |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfGJiFeEN8ERjEICQkpLE2cOHlAaEWdxqZWU1lFxYvlz67SlIy0Bfrfc-emZRETog956J2T9j5855x9P0LeKKkkRIIiVIkzIZNGhRAVWciNjY0zWZH4dgyDYXY8ZieTdLJDNvBWjQDnNy7tEE9qXF--__V99REc_oN3-Dw7mMMcm-MWNHAXxtMQZuQ9CEwcAQ0G7E9RgeceoK4L8zEWFXhT5LzxFq0w5bv5_z1nXwta7Q2V1yLU0T1yt0kt6eHaFu6THVs-ILcHTfH8Ifl6XldXMbXlBWp6TmflD4nvymjlKKirrmaGaiTVVK2AapYwbkoHg7OYNnA-tD86pbI09GR4ShHM-KdczR-R8VH__NNx2OAqhDoruotQ6SyWTMJSxUmHCHOqcAlo0tnIFtpETrPU8q6C1Unu0jhV1ibGFKmKU9BgZJLHZLesSvuUUJVz5VwhdWol01orx5S2cSpd5CzTPCDRRoxCN03HEfviUvjFR56JteQFSF6g5EUckHfbIVfrjhv_Yu6hbraM2Czbf1HVU9H4nmDwm_Pc5XnRlcxGqYIsSillssRF3CodkJeoWbE-ebp1eXGIyWgOCTI85rXnwIYZJe7ImcrlfC4-fxm1mN42TK6C_6hlc8ABJIU9tlqc-y1O8GjdJm9MTGwcQkAmnsYcPnlAXm3JOBJ3yZW2Wnoef_6TRwF5srbIrWSwoF2A0QeEt2y1Jbo2pZxd-H7jiAEEaeiz_xHCc3InRi_C1qNsn-wu6qV9AWnbQnXILT7hHbLX6w_PRh3_8qPjHRSuo963372HQkg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXxDeFwQwCISFFS10ncR4QGrCpXdcKjU30zfizq4SS0rRM_af4G7lL0rAIaW_rY-_cOuf7-Dk-3xHyRiutIBKkge55G3BldQBRkQeJdcx6G6e9shzDaBz3z_jRJJpskT-buzCYVrnxiaWjtrnBd-R7gEQilsBHfJz_CrBrFJ6ublpoVGoxdOsL2LIVHwZfYH3fMnZ4cPq5H9RdBQITp91loE3MFFcA1L3y2F9Np74Hz-Fd6FJjQ2945JKuBmwufMQi7VzP2jTSLIL5h7YHv3uD3ITAG-JmL5k0G7xuIkJRn5x2RbxXgO8XmBoHZsyTKGCt2Fe2CPg_EFyKhO0szUth7_AeuVvjVbpfKdh9suWyB-TWqD6Rf0i-ny7yOaMuO0f1Kegs-63wBRzNPQUdWOQzSw2SFlSvgWpXMG5KR6OvjNY9gujByZCqzNKj8ZBih-QLtS4ekbNrEetjsp3lmXtKqBaJ9j5VJnKKG2O059o4FikfesdN0iHhRozS1JXMsaHGT1nuaEQsK8lLkLxEyUvWIe-bIfOqjMdVzJ9wbRpGrMBdfpEvprI2aMlhzkJ4IdKu4i6MNEAzrbWNez5MnDYdsosrK6vrrI0fkfuIcAWgbvib1yUHVuHIMM1nqlZFIQffTlpM72omn8MzGlXfmgBJYeGuFudOixPchGmTNyomazdVyH9G1SGvGjKOxNS7zOWrkqe8VJqEHfKk0shGMnhKnvIQViRp6WpLdG1KNjsvi5hjYyHAts-untYuud0_HR3L48F4-JzcYWhLWNWU75Dt5WLlXgAiXOqXpRlS8uO67f4v9bJ2SQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trop2+enhances+invasion+of+thyroid+cancer+by+inducing+MMP2+through+ERK+and+JNK+pathways&rft.jtitle=BMC+cancer&rft.au=Guan%2C+Hongyu&rft.au=Guo%2C+Zejun&rft.au=Liang%2C+Weiwei&rft.au=Li%2C+Hai&rft.date=2017-07-14&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2407&rft.eissn=1471-2407&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs12885-017-3475-2&rft.externalDBID=ISR&rft.externalDocID=A511289772 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |